Lack of association between PADI4 and functional severity in Japanese rheumatoid arthritis patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2007-10-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2007.071084PMID 18292109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis

  2006cited by this paper
• Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA

  2006cited by this paper
• Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.

  2006cited by this paper
• Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis

  2005cited by this paper
• Association between PADI4 and rheumatoid arthritis: a replication study.

  2005cited by this paper
• Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

  2005cited by this paper
• Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis.

  2003cited by this paper
• Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis

  2003cited by this paper
• Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis

  2003cited by this paper
• The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.

  2001cited by this paper
• Bone mass in ankylosing spondylitis.

  1986cited by this paper

• Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group

  2016cites this paper
• Statistical Modelling of Markers of Severity in Rheumatoid Arthritis

  2014cites this paper
• PADI2 Is Significantly Associated with Rheumatoid Arthritis

  2013cites this paper
• PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.

  2012cites this paper
• Peptidylarginine Deiminase Type 4 and Methyl-CpG Binding Domain 4 Polymorphisms in Chinese Patients with Rheumatoid Arthritis

  2012cites this paper
• Peptidylarginine deiminases: physiological function, interaction with chemokines and role in pathology.

  2012cites this paper
• Polymorphismes de PADI4 et de ses haplotypes chez les patients atteints de polyarthrite rhumatoïde

  2012cites this paper
• [108th Scientific Meeting of the Japanese Society of Internal medicine: invited lecture: 5. IORRA, a large cohort study for rheumatoid arthritis in Japan].

  2011cites this paper
• Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men.

  2009cites this paper